Longitudinal Population-based Observational Study of COVID-19 in the UK Population (COVIDENCE UK)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04330599 |
Recruitment Status :
Active, not recruiting
First Posted : April 1, 2020
Last Update Posted : January 31, 2022
|
Sponsor:
Queen Mary University of London
Collaborators:
King's College London
London School of Hygiene and Tropical Medicine
University of Edinburgh
Swansea University
Queen's University, Belfast
Barts & The London NHS Trust
Information provided by (Responsible Party):
Queen Mary University of London
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | March 31, 2020 | ||||
First Posted Date | April 1, 2020 | ||||
Last Update Posted Date | January 31, 2022 | ||||
Actual Study Start Date | May 1, 2020 | ||||
Estimated Primary Completion Date | April 1, 2025 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
Incidence of confirmed COVID-19 [ Time Frame: 5 years ] | ||||
Original Primary Outcome Measures |
Incidence of suspected, probable or confirmed COVID-19 [ Time Frame: 5 years ] | ||||
Change History | |||||
Current Secondary Outcome Measures |
|
||||
Original Secondary Outcome Measures |
|
||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Longitudinal Population-based Observational Study of COVID-19 in the UK Population | ||||
Official Title | Longitudinal Population-based Observational Study of COVID-19 in the UK Population | ||||
Brief Summary | COVIDENCE UK is a population-based observational longitudinal study that has the following objectives:
|
||||
Detailed Description | Not Provided | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Cohort Time Perspective: Prospective |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Retention: Samples Without DNA Description: Eluates from dried blood spots
|
||||
Sampling Method | Non-Probability Sample | ||||
Study Population | UK residents aged 16 years or more | ||||
Condition | COVID-19 | ||||
Intervention | Not Provided | ||||
Study Groups/Cohorts | Not Provided | ||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Active, not recruiting | ||||
Actual Enrollment |
13000 | ||||
Original Estimated Enrollment |
12000 | ||||
Estimated Study Completion Date | April 1, 2025 | ||||
Estimated Primary Completion Date | April 1, 2025 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria: none |
||||
Sex/Gender |
|
||||
Ages | 16 Years and older (Child, Adult, Older Adult) | ||||
Accepts Healthy Volunteers | Yes | ||||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||||
Listed Location Countries | United Kingdom | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT04330599 | ||||
Other Study ID Numbers | COVIDENCE UK | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement |
|
||||
Current Responsible Party | Queen Mary University of London | ||||
Original Responsible Party | Same as current | ||||
Current Study Sponsor | Queen Mary University of London | ||||
Original Study Sponsor | Same as current | ||||
Collaborators |
|
||||
Investigators | Not Provided | ||||
PRS Account | Queen Mary University of London | ||||
Verification Date | January 2022 |